Corticobasal Degeneration Awareness Month

01/01/2019

WHEREAS, Corticobasal Degeneration (CBD/CBGD) is a progressive neurological disorder characterized by nerve cell loss and atrophy of multiple areas of the brain, including the cerebral cortex and the basal ganglia; and

WHEREAS, Corticobasal Degeneration was first identified in 1968, distinguishing it from Parkinson's disease; and

WHEREAS, initial symptoms, which typically begin at or around age 60, may first appear on one side of the body, but eventually affect both sides as the disease progresses; and

WHEREAS, symptoms include poor coordination, akinesia (an absence of movements), rigidity (a resistance to imposed movement), disequilibrium (impaired balance), and limb dystonia (abnormal muscle postures); and

WHEREAS, other symptoms can include cognitive and visual-spatial impairments, apraxia (loss of the ability to make familiar, purposeful movements), hesitant and halting speech, muscular jerks, and difficulty swallowing; and

WHEREAS, Corticobasal Degeneration usually progresses slowly over the course of six to eight years, and death is generally caused by pneumonia or other complications of severe debility; and

WHEREAS, there is no treatment available to slow the course of corticobasal degeneration, and the symptoms of the disease are generally resistant to therapy; and

WHEREAS, raising public awareness of this disease can result in earlier diagnosis, improved medical treatment, increased research, and better access to quality health care; and

WHEREAS, Corticobasal Degeneration Awareness Month recognizes the patients and families affected and brings to light the need for further research and understanding of the disease;

NOW, THEREFORE, I, Ralph S. Northam, do hereby recognize January 2019 as CORTICOBASAL DEGENERATION AWARENESS MONTH in our COMMONWEALTH OF VIRGINIA, and I call this observance to the attention of all our citizens.